Genentech Cathflo Activase Approved With 30-Minute Dwell Time
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Genentech’s Cathflo Activase (alteplase) was approved Sept. 4 with a 30-minute dwell time for clearing blocked catheters and ports.